Fact CheckerSign in

NCT06850350Recruiting

Cognitive-Sensorimotor Function in Long-COVID

Enhancing Veterans Long-COVID Care: A Cognitive-Sensorimotor Framework to Understand Gait and Balance Dysfunction

Source: ClinicalTrials.gov · Last updated 8 May 2026

Brief summary (registry, in English)

Growing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and musculoskeletal impairment that can affect gait and balance. Identifying the factors contributing to these impairments and how they influence functional mobility is the first step towards creating effective evaluation and treatment protocols. In this study the investigators will examine cognition, vision, proprioception, muscle strength, gait and balance in persons with and without PASC to understand how PASC may impact functional mobility through a cognitive-sensorimotor lens. Gait and balance will be studied in environments that stress cognitive and sensory abilities. Study outcomes will be critical for the development of evidence-based Veteran Health Administration diagnostic and standard-of-care protocols to address gait and balance dysfunction in Veterans with PASC for restoring their functional mobility and independence.

Status (registry)
Recruiting
Study type
Observational
Enrollment
136 (estimated)
First submitted
26 Feb 2025
Start date
1 Apr 2026
Primary completion date
31 Dec 2030
Lead sponsor
VA Office of Research and Development
NCT number
NCT06850350

What you commit to

  • Study type: Observational
  • Planned participants: 136
  • From 1 Apr 2026 to the primary completion date, 31 Dec 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of severe cardiovascular and pulmonary disease and/or neurological and musculoskeletal disorders unrelated to COVID-19 (e.g., amputation, stroke, spinal cord injury)
  • Severe acute COVID-19 infection requiring hospitalization or diagnosed post-intensive care syndrome.
  • Presence of musculoskeletal, inflammatory, or neurological conditions mimicking Long COVID-19 symptoms (e.g., concussion within last 5 years, Chronic fibromyalgia, Myofascial pain syndrome, etc.)

Other

  • Cognitive impairments precluding ability to provide informed consent.

Who the study is looking for

  • Older than 18 years of age
  • Positive PCR or Rapid COVID-19 test in the past
  • Onset of COVID-19 illness greater than 3 months prior to their participation in the study
  • Self-reported ability to walk 10 meters with or without external assistance prior to COVID-19 illness

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jesse Brown VA Medical Center, Chicago, IL
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.